Literature DB >> 21623829

A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family.

M F Ferraro1, A S Moreno, E C Castelli, E A Donadi, M S Palma, H A Arcuri, A P Lange, K Bork, W Sarti, L K Arruda.   

Abstract

BACKGROUND: Hereditary angioedema is an autosomal dominant disease characterized by episodes of subcutaneous and submucosal edema. It is caused by deficiency of the C1 inhibitor protein, leading to elevated levels of bradykinin. More than 200 mutations in C1 inhibitor gene have been reported. The aim of this study was to analyze clinical features of a large family with an index case of hereditary angioedema and to determine the disease-causing mutation in this family.
METHODS: Family pedigree was constructed with 275 individuals distributed in five generations. One hundred and sixty-five subjects were interviewed and investigated for mutation at the C1 inhibitor gene. Subjects reporting a history of recurrent episodes of angioedema and/or abdominal pain attacks underwent evaluation for hereditary angioedema.
RESULTS: We have identified a novel mutation at the C1 inhibitor gene, c.351delC, which is a single-nucleotide deletion of a cytosine on exon 3, resulting in frameshift with premature stop codon. Sequencing analysis of the hypothetical truncated C1 inhibitor protein allowed us to conclude that, if transcription occurs, this protein has no biological activity. Twenty-eight members of the family fulfilled diagnostic criteria for hereditary angioedema and all of them presented the c.351delC mutation. Variation in clinical presentation and severity of disease was observed among these patients. One hundred and thirty-seven subjects without hereditary angioedema did not have the c.351delC mutation.
CONCLUSION: The present study provides definitive evidence to link a novel genetic mutation to the development of hereditary angioedema in patients from a Brazilian family.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623829     DOI: 10.1111/j.1398-9995.2011.02658.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

1.  In Search of an Association Between Genotype and Phenotype in Hereditary Angioedema due to C1-INH Deficiency.

Authors:  David Loli-Ausejo; Alberto López-Lera; Christian Drouet; Marina Lluncor; Elsa Phillips-Anglés; María Pedrosa; Rosario Cabañas; Teresa Caballero
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-19       Impact factor: 8.667

2.  Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.

Authors:  Karlijn J G Schulkes; Mignon T Van den Elzen; Erik C Hack; Henderikus G Otten; Carla A F M Bruijnzeel-Koomen; André C Knulst
Journal:  Clin Transl Allergy       Date:  2015-02-04       Impact factor: 5.871

3.  A hereditary angioedema screening in two villages, based on an index case, and identification of a novel mutation, "1033G>T", at the SERPING1 gene.

Authors:  Mehmet Yasar Ozkars; Ozlem Keskın; Nazan Bayram; Huseyin Onay; Mehmet Keskın; Hasan Bayram; Yavuz Sahın; Ercan Küçükosmanoğlu; Serkan Kırık
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

4.  Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.

Authors:  Anete S Grumach; Marina T Henriques; Maine L D Bardou; Daniele A Pontarolli; Jaco Botha; Mariangela Correa
Journal:  An Bras Dermatol       Date:  2022-05-30       Impact factor: 2.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.